Searle acquires two cardiovascular drugs from AstraZeneca in Europe and Scandinavia Nov. 5, 1999 No Comments
MCC-135 restores impaired Ca2+-ATPase activity in the postischemic myocardium Nov. 3, 1999 No Comments
Rock/Rho kinase inhibitor Y-27632: a promising vasodilator for treatment of heart failure Nov. 3, 1999 No Comments
RSS